What We're Reading: Page 65
Industry reads hand-picked by our editors
Feb 26, 2024
-
Fierce Biotech
J&J to close Bay Area R&D site less than 18 months after opening
-
The Denver Post
Enbrel price cap OK’d by Colorado Prescription Drug Affordability Board
-
The Pharma Letter
FDA issues final decision to withdraw Pepaxto accelerated approval
-
The New York Times
Drug Drastically Reduces Children’s Reactions to Traces of Food Allergens
Feb 23, 2024
-
Science
A deadly viral illness is exploding in West Africa. Researchers are scrambling to figure out why
-
Reuters
US bill on Chinese biotech firms may be more ‘narrowly tailored’, lawmaker says
-
Fierce Biotech
GSK, Vir end flu drug alliance, removing key piece of $345M pact
-
New York Magazine
The Empty Adderall Factory
Feb 22, 2024
-
BioSpace
PhRMA Names Gilead CEO O’Day as New Board Chair Following Loss of Members
-
Reuters
Emergent appoints former Bausch + Lomb CEO to head company
-
Axios
Alabama Supreme Court ruling adds to legal uncertainty around IVF
-
Wired
Neuralink’s First Brain Implant Is Working. Elon Musk’s Transparency Isn’t
Feb 21, 2024
Feb 20, 2024
Feb 16, 2024
Feb 15, 2024
-
Los Angeles Times
Inside the plan to diagnose Alzheimer’s in people with no memory problems — and who stands to benefit
-
CNN
First frostbite treatment approved by FDA
-
Bloomberg
WuXi AppTec, WuXi Bio Slump as US Lawmakers Seek Formal Probe
-
Fierce Pharma
Lilly, with approval in sight, runs ad about Alzheimer’s impact
Previous
